ZEAL and ZEAL:DC Related Headlines
Go Back- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK425 at Barclays
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK505 at Jefferies
- Wolfe Research Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Outperform
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK491 at Goldman Sachs
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK275 at Deutsche Bank
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK460 at JPMorgan
- William Blair Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Market Perform, Removed from Analyst Conviction List
- Cantor Fitzgerald Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Neutral
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK700 at UBS
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK630 at Jefferies
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Raised to DKK450 at Deutsche Bank
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK825 at Berenberg
- UBS Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Buy
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK1,050 at JPMorgan
- Wells Fargo Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Overweight
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK400 at Deutsche Bank
- Barclays Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Overweight
- BNP Paribas Exane Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Outperform
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK850 at Berenberg
- Zealand Pharma A/S (ZEAL:DC) (ZEAL) PT Lowered to DKK850 at Berenberg

